SCHEMBL18610833

SCHEMBL18610833

NC(N)c1c[nH]c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21789414 0.69 ATAD2 (0.39) —
SCHEMBL20878330 0.69 GAA (0.39) —
SCHEMBL18373246 0.67 GAA (0.38) —
SCHEMBL18476607 0.65 — —
SCHEMBL887700 0.64 ATAD2 (0.48) —
SCHEMBL29181403 0.63 LMNA (0.36) —
SCHEMBL18783134 0.60 DPYD (0.50) —
Hydrochloric Acid SCHEMBL29256236 0.60 DPYD (0.50) —
Potassium SCHEMBL29524710 0.60 DPYD (0.50) —
SCHEMBL2888210 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10011612-B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders ACHILLION PHARMACEUTICALS, INC. (US) 2018-07-03 — — US disclosed
US-20170066783-A1 Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-09 — — US disclosed
Send feedback